ClinicalTrials.Veeva

Menu

Ambulant Monitoring to Detect Hemodynamic and Electrical Impact of Severe Tricuspid Valve Regurgitation

U

Universitaire Ziekenhuizen KU Leuven

Status

Completed

Conditions

Tricuspid Regurgitation (TR)

Treatments

Diagnostic Test: 14 days ambulatory rhythm monitoring

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This exploratory study aims to study the feasibility to detect early signs of disease progression in patients with severe TVR (grade ≥3/4) by monitoring electrical cardiac activity and correlating it with echocardiographic findings. The Byteflies monitoring device will be used for continuous 14-day outpatient ECG tracking. Transthoracic echocardiography will assess structural and pressure changes in the heart and liver. The goal is to improve early detection of right heart failure and hepatic congestion.

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Tricuspid valve regurgitation (TVR) grade ≥3/4 documented on Colour Doppler during routine transthoracic echocardiography
  • Normal sinus rhythm
  • Dutch speaking

Exclusion criteria

  • History of cardiac surgery
  • Abnormal rhythm at baseline visit
  • Age <18 years

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

14 days ambulatory rhtyhm monitoring
Experimental group
Description:
14 days ambulatory rhtyhm monitoring to detect electrical instability
Treatment:
Diagnostic Test: 14 days ambulatory rhythm monitoring

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems